Prof. Ehud Shapiro leads research that shows how leukemia can evade chemotherapy. Using his method of mapping the family trees of cells, the team found that slowly dividing cancer cells are most likely to survive the toxic therapy. This could lead to new ways of fighting cancer.
Do you know that skin cancer is the most common form of cancer? It has been on the rise for the past 30 years, and the American Cancer Society estimates that, in 2013, almost 77,000 new melanomas will be diagnosed in the U.S. alone. Learn how the Weizmann Institute is fighting this disease.
Prof. Avri Ben-Ze'ev has long studied the role of a gene called beta-catenin in various cancers, including identifying Nr-CAM, which is unleashed by beta-catenin's signaling. Not previously known to play a role in cancer, Nr-CAM is dramatically elevated in colon cancer and melanoma cells.
Prof. Michel Revel of the Department of Molecular Genetics isolated interleukin-6, or IL-6, an immune system protein that can also play a role in cancer treatment.
The American Committee for the Weizmann Institute of Science's South Florida Region celebrated four women who are leading their community via philanthropy, pediatric causes, and more.
The Weizmann Institute's Nobel Prize-winning chemist Prof. Ada Yonath answers questions from Nature about persistence, gender, ribosomes, and what it takes to be a scientist.
October is National Breast Cancer Awareness Month. Read about some of the groundbreaking research taking place at the Weizmann Institute to combat this all-too-common disease.
As The New York Times reports, the work of Weizmann's Prof. Zelig Eshhar on genetically doctoring T-cells led to the University of Pennsylvania using such cells to fight leukemia, resulting in remission.
September 13, 2011
Weizmann Institute scientist's vision: Microscopic computers will function inside living tissues, performing diagnosis and administering treatment.
©2018 American Committee for the Weizmann Institute of Science
